(in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 |
---|---|---|---|---|
Current assets | ||||
Cash | $9095 | $17011 | $13700 | |
Short term investments | $1226 | $853 | $1534 | |
Net receivables | $2779 | $2542 | $2285 | |
Inventory | $17075 | $18001 | $16651 | |
Total current assets | $32146 | $40080 | $35879 | |
Long term investments | ||||
Property, plant & equipment | $30341 | $29840 | $29397 | |
Goodwill & intangible assets | ||||
Total noncurrent assets | $34177 | $33643 | $33115 | |
Total investments | $1226 | $853 | $1534 | |
Total assets | $66323 | $73723 | $68994 | |
Current liabilities | ||||
Accounts payable | $17494 | $20357 | $17483 | |
Deferred revenue | $2541 | $2462 | $2337 | |
Short long term debt | $1080 | $1080 | $1081 | |
Total current liabilities | $34688 | $36768 | $33583 | |
Long term debt | $8353 | $8267 | $7803 | |
Total noncurrent liabilities | $10875 | $10808 | $10353 | |
Total debt | $9433 | $9347 | $8884 | |
Total liabilities | $45563 | $47576 | $43936 | |
Shareholders' equity | ||||
Retained earnings | $14980 | $20499 | $19521 | |
Other shareholder equity | -$1842 | -$1843 | -$1805 | |
Total shareholder equity | $20760 | $26147 | $25058 |
(in millions $) | 31 Jan 2024 | 28 Sep 2022 | 1 Oct 2021 | 31 Dec 2020 |
---|---|---|---|---|
Current assets | ||||
Cash | $13700 | $10203 | $11258 | $12277 |
Short term investments | $1534 | $846 | $917 | $1028 |
Net receivables | $2285 | $2241 | $1803 | $1550 |
Inventory | $16651 | $17907 | $14215 | $12242 |
Total current assets | $35879 | $32696 | $29505 | $28120 |
Long term investments | ||||
Property, plant & equipment | $29397 | $27420 | $23492 | $24595 |
Goodwill & intangible assets | ||||
Total noncurrent assets | $33115 | $31470 | $29763 | $27436 |
Total investments | $1534 | $846 | $917 | $1028 |
Total assets | $68994 | $64166 | $59268 | $55556 |
Current liabilities | ||||
Accounts payable | $17483 | $17848 | $16278 | $14172 |
Deferred revenue | $2337 | $2174 | $2042 | $1851 |
Short long term debt | $1081 | $73 | $799 | $95 |
Total current liabilities | $33583 | $31998 | $29441 | $24844 |
Long term debt | $7803 | $6484 | $6692 | $10072 |
Total noncurrent liabilities | $10353 | $11521 | $11749 | $12007 |
Total debt | $8884 | $9039 | $10133 | $10167 |
Total liabilities | $43936 | $43524 | $41190 | $36851 |
Shareholders' equity | ||||
Retained earnings | $19521 | $15585 | $11666 | $12879 |
Other shareholder equity | -$1805 | -$1829 | -$623 | -$1297 |
Total shareholder equity | $25058 | $20642 | $17564 | $18284 |
(in millions $) | 30 Jul 2024 | 31 Mar 2024 | 31 Jan 2024 | 30 Sep 2023 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $58442 | $78939 | ||
Cost of revenue | $51140 | $69219 | ||
Gross Profit | $7302 | $9720 | ||
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $5240 | $6939 | ||
Total operating expenses | $5240 | $6939 | ||
Operating income | $2062 | $2781 | ||
Income from continuing operations | ||||
EBIT | $2278 | $3019 | ||
Income tax expense | $494 | $803 | ||
Interest expense | $41 | $56 | ||
Net income | ||||
Net income | $1743 | $2160 | ||
Income (for common shares) | $1743 | $2160 |
(in millions $) | 31 Jan 2024 | 28 Sep 2022 | 1 Oct 2021 | 31 Dec 2020 |
---|---|---|---|---|
Revenue | ||||
Total revenue | $226954 | $195929 | $166761 | |
Cost of revenue | $144939 | |||
Gross Profit | $27572 | $25245 | $21822 | |
Operating activities | ||||
Research & development | ||||
Selling, general & administrative | $16332 | |||
Total operating expenses | $19779 | $18537 | $16387 | |
Operating income | $6708 | $5435 | ||
Income from continuing operations | ||||
EBIT | $5470 | |||
Income tax expense | $1925 | $1601 | $1308 | |
Interest expense | $47 | $171 | $160 | |
Net income | ||||
Net income | $5844 | $5007 | $4002 | |
Income (for common shares) | $4002 |
(in millions $) | 31 Mar 2024 | 31 Dec 2023 | 30 Sep 2023 | 30 Jun 2023 |
---|---|---|---|---|
Net income | $1743 | $1589 | $2160 | $1302 |
Operating activities | ||||
Depreciation | $588 | $575 | $800 | $556 |
Business acquisitions & disposals | ||||
Stock-based compensation | $136 | $444 | $131 | $94 |
Total cash flows from operations | $731 | $4651 | $3725 | $1541 |
Investing activities | ||||
Capital expenditures | -$1031 | -$1040 | -$1556 | -$820 |
Investments | -$368 | $678 | -$332 | -$469 |
Total cash flows from investing | -$1386 | -$366 | -$1825 | -$1282 |
Financing activities | ||||
Dividends paid | -$7107 | -$905 | -$452 | -$399 |
Sale and purchase of stock | -$160 | -$162 | -$230 | -$162 |
Net borrowings | -$9 | $387 | -$278 | -$65 |
Total cash flows from financing | -$7276 | -$974 | -$664 | -$735 |
Effect of exchange rate | $15 | -$29 | -$1 | |
Change in cash and equivalents | -$7916 | $3311 | $1207 | -$477 |
(in millions $) | 31 Dec 2023 | 31 Dec 2022 | 1 Oct 2021 | 31 Dec 2020 |
---|---|---|---|---|
Net income | $6292 | $5844 | $4002 | |
Operating activities | ||||
Depreciation | $2489 | $2277 | $1839 | |
Business acquisitions & disposals | -$1163 | |||
Stock-based compensation | $774 | $724 | $619 | |
Total cash flows from operations | $11068 | $7392 | $8861 | |
Investing activities | ||||
Capital expenditures | -$4323 | -$3891 | -$2810 | |
Investments | -$685 | $24 | $52 | |
Total cash flows from investing | -$4972 | -$3915 | -$3891 | |
Financing activities | ||||
Dividends paid | -$1251 | -$1498 | -$1479 | |
Sale and purchase of stock | -$676 | -$439 | -$196 | |
Net borrowings | -$384 | -$800 | $929 | |
Total cash flows from financing | -$2614 | -$4283 | -$1147 | |
Effect of exchange rate | $15 | -$249 | $70 | |
Change in cash and equivalents | $3497 | -$1055 | $3893 |
Market cap | N/A |
---|---|
Enterprise value | N/A |
Shares outstanding | N/A |
Revenue | N/A |
---|---|
EBITDA | N/A |
EBIT | N/A |
Net Income | N/A |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
P/E ratio | N/A |
---|---|
EV/Sales | N/A |
EV/EBITDA | N/A |
EV/EBIT | N/A |
P/S ratio | N/A |
P/B ratio | N/A |
Book/Share | N/A |
Cash/Share | N/A |
EPS | N/A |
---|---|
ROA | N/A |
ROE | N/A |
Debt/Equity | 1.75 |
---|---|
Net debt/EBITDA | N/A |
Current ratio | N/A |
Quick ratio | N/A |